Garbero, Elena
Livigni, Sergio
Ferrari, Fiorenza
Finazzi, Stefano
Langer, Martin
Malacarne, Paolo
Meca, Manlio Cosimo Claudio
Mosca, Sabino
Olivieri, Carlo
Pozzato, Marco
Rossi, Carlotta http://orcid.org/0000-0001-9133-971X
Tavola, Mario
Terzitta, Marina
Viaggi, Bruno
Bertolini, Guido
,
Bonato, Valeria
Calamai, Italo
Fiore, Gilberto
Gori, Valentina
Lefons, Ugo
Livigni, Sergio
Meca, Manlio Cosimo Claudio
Meinardi, Stefano
Nattino, Giuseppe
Tedeschi, Luisa
Terzitta, Marina
Zuccaro, Francesco
Clinical trials referenced in this document:
Documents that mention this clinical trial
The premature closure of ROMPA clinical trial: mortality reduction in septic shock by plasma adsorption
https://doi.org/10.1136/bmjopen-2019-030139
High dose coupled plasma filtration and adsorption in septic shock patients. Results of the COMPACT-2: a multicentre, adaptive, randomised clinical trial
https://doi.org/10.1007/s00134-021-06501-3
Chemical and microbiological stability, anticoagulant efficacy and toxicity of 35 and 90 mM trisodium citrate solutions stored in plastic syringes
https://doi.org/10.1136/ejhpharm-2016-001094
Funding for this research was provided by:
Bellco
Article History
Received: 6 April 2021
Accepted: 2 August 2021
First Online: 3 October 2021
Declarations
:
: BV reports grants from Pfizer, Nordic Pharma, MSD Italia, Angelini, Cepheid, Becton Dickinson, Biomerieux, Gilead, outside the submitted work. CO reports personal fees from Intersurgical SpA, outside the submitted work. All other authors declare no competing interests.
: The COMPACT-2 study was approved by the Ethical Committee of the Coordinating Center of the project, Ospedale San Giovanni Bosco of Turin, and subsequently by all participating centers’ Ethics Committees.
: Written informed consent was obtained according to Italian legislation.
: Not applicable.